ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
FOXO Technologies Inc. (FOXO) stock declined over -9.49%, trading at $0.12 on AMEX, down from the previous close of $0.14. The stock opened at $0.14, fluctuating between $0.12 and $0.14 in the recent session.
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.
Employees | 4 |
Beta | 3.52 |
Sales or Revenue | $511.00K |
5Y Sales Change% | 0.408% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Healthcare Information Services |